SCHEMBL5653552

SCHEMBL5653552

CCOC(=O)c1sc2c(ccc(=O)n2-c2ccccc2)c1-c1cccc(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
HPGD P15428 3/20 0.48
HSD17B10 Q99714 2/20 0.48
ALOX15 P16050 1/20 0.48
THRB P10828 1/20 0.45
MAPT P10636 5/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
PRNP P04156 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
DHODH Q02127 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TP53 P04637 2/20 0.42
MAT2A P31153 1/20 0.42
GNRHR P30968 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5653063 0.95 ALDH1A1 (0.52) ALDH1A1HPGDHSD17B10ALOX15THRB
SCHEMBL5650917 0.90 MAPT (0.46) ALDH1A1HPGDHSD17B10ALOX15MAPT
SCHEMBL5650136 0.90 MAPT (0.51) ALDH1A1HPGDHSD17B10MAPTNPSR1
SCHEMBL5652346 0.89 MAPT (0.47) ALDH1A1HPGDHSD17B10ALOX15MAPT
SCHEMBL5647395 0.89 MAPT (0.50) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL5651738 0.89 TRPM8 (0.48) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL5668234 0.89 TRPM8 (0.48) ALDH1A1HPGDHSD17B10THRBMAPT
SCHEMBL5651739 0.86 ALDH1A1 (0.44) ALDH1A1HPGDHSD17B10ALOX15MAPT
SCHEMBL5650036 0.86 FNTA (0.53) ALDH1A1HPGDHSD17B10ALOX15MAPT
SCHEMBL5650443 0.86 MAPT (0.50) ALDH1A1HPGDHSD17B10MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176215-B2 Bicyclic oxopyridine and oxopyrimidine derivatives CELLTECH R&D LIMITED (GB) 2007-02-13 US claimed
US-20050059681-A1 Far field light microscopical method system and computer program product for analysing at least one object having a subwavelength size RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) 2005-03-17 US claimed
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives UCB PHARMA S.A. (BE) 2004-12-16 US claimed
US-7176215-B2 Bicyclic oxopyridine and oxopyrimidine derivatives CELLTECH R&D LIMITED (GB) 2007-02-13 US disclosed
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives UCB PHARMA S.A. (BE) 2004-12-16 US disclosed
EP-1438313-A1 BICYCLIC OXOPYRIDINE AND OXOPYRIMIDINE DERIVATIVES Celltech R & D Limited (GB) 2004-07-21 EP disclosed
WO-2003033502-A1 BICYCLIC OXOPYRIDINE AND OXOPYRIMIDINE DERIVATIVES CELLTECH R & D LIMITED (GB) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059681-A1 Far field light microscopical method system and computer program product for analysing at least one object having a subwavelength size CFL1, INF2, COG6 ALDH1A1 2400/4885HPGD 3158/4885HSD17B10 4549/4885
US-20040254200-A1 Bicyclic oxopyridine and oxopyrimidine derivatives MAPK1, ALK, NAT1 ALDH1A1 1498/4885HPGD 1929/4885HSD17B10 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.